[O-29] Oral Session 29 Clinical trial and Regenerative medicine2

[O-29-2] Analysis of Efgartigimod Efficacy Across Patient Populations and Myasthenia Gravis Specific Scales

^○Hiroyuki Murai¹, Vera Bril², Tuan Vu³, Chafic Karam⁴, Stojan Peric⁵, Tomihiro Imai⁶, Masanori Takahashi⁷, Akiyuki Uzawa⁸, Antonio Guglietta⁹, Peter Ulrichts⁹, Tony Vangeneugden⁹, Kimiaki Utsugisawa¹⁰, Renato Mantegazza¹¹, James F. Howard¹² (1.International University of Health and Welfare, Japan, 2.Krembil Neuroscience Centre, 3.University of South Florida, 4.Hospital of the University of Pennsylvania, 5.Wroclaw Medical University, 6.Sapporo Medical University, 7.Osaka University, 8.Chiba University, 9.argenx, 10.Hanamaki General Hospital, 11.Fondazione Istituto Neurologico Carlo Besta, 12.The University of North Carolina)